Learn More
Invitrogen™ DEDD Polyclonal Antibody

Description
Recommended positive controls: mouse leukocyte treated with CFA. Predicted reactivity: Mouse (100%), Rat (100%), Xenopus laevis (100%), Rhesus Monkey (100%), Bovine (100%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Specifications
Specifications
| Antigen | DEDD |
| Applications | Western Blot, Immunocytochemistry |
| Classification | Polyclonal |
| Concentration | 0.42 mg/mL |
| Conjugate | Unconjugated |
| Formulation | 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 |
| Gene | DEDD |
| Gene Accession No. | O75618, Q9Z1L3 |
| Gene Alias | CASP8IP1; death effector domain containing; death effector domain-containing; death effector domain-containing protein; Death effector domain-containing testicular molecule; DEDD; DEDD1; Dedpro1; DEFT; FLDED1; FLDED-1; KE05; tumor necrosis factor (ligand) superfamily, member 19 |
| Gene Symbols | DEDD |
| Show More |
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.